Literature DB >> 14734940

Cross-sectional versus longitudinal performance assessments in the management of diabetes.

Mark Weiner1, Judith Long.   

Abstract

BACKGROUND: Performance assessments help to quantify the level of adherence with practice standards and are often used to measure and compare the quality of care. However, most performance assessments are based on a cross-sectional analysis of patient information, whereas patient care is inherently longitudinal. This discordance could confound the relationship between the performance measure and the true quality of care.
OBJECTIVE: The objective of this study was to illustrate differences in performance assessment as measured by a traditional cross-sectional analysis compared with a longitudinal analysis.
METHODS: We conducted a cross-sectional and longitudinal analysis of a cohort of diabetic patients in an integrated delivery system having primary care visits and hemoglobin A1c (HBA1c) testing in both 1999 and 2000.
RESULTS: In the cross-sectional analysis of 4661 patients, we found a modestly increasing proportion achieved an HBA1c level of <8.0%: 73.1% in 1999 and 75.6% in 2000. Longitudinal analysis, however, suggested that certain subsets of patients were more likely to switch from good to poor control or retain their level of poor control over the 2 years studied. In particular, compared with whites, blacks were 1.76 (95% confidence interval [CI], 1.31-2.37) times as likely to switch from good to poor control and only 0.56 (95% CI, 0.41-0.76) times as likely to switch from poor to good control. Patients aged 35 to 49 were 2.54 (95% CI, 1.79-3.45) times as likely to switch from good to poor and only 0.66 (95% CI, 0.47-0.94) times as likely to switch from poor to good control than patients over age 64 years.
CONCLUSIONS: Cross-sectional performance assessments could mask changes in diabetes control among individuals belonging to a cohort and, conceptually, are poorer indicators of care process than longitudinal measures. In addition, longitudinal analyses suggest the influence of patient sociodemographic factors on the performance assessment that should be accounted for when comparing quality of care for diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734940     DOI: 10.1097/01.mlr.0000109167.86509.24

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  6 in total

1.  Home health care may improve diabetic outcomes among non-English speaking patients in primary care practice: a pilot study.

Authors:  Douglas L Nguyen; Ramona S DeJesus
Journal:  J Immigr Minor Health       Date:  2011-10

2.  Assessing quality of diabetes care by measuring longitudinal changes in hemoglobin A1c in the Veterans Health Administration.

Authors:  Wes Thompson; Hongwei Wang; Minge Xie; John Kolassa; Mangala Rajan; Chin-Lin Tseng; Stephen Crystal; Quanwu Zhang; Yehuda Vardi; Leonard Pogach; Monika M Safford
Journal:  Health Serv Res       Date:  2005-12       Impact factor: 3.402

3.  Influence of chronic comorbidity and medication on the efficacy of treatment in patients with diabetes in general practice.

Authors:  Welcome Mkululi Wami; Frank Buntinx; Stefaan Bartholomeeusen; Geert Goderis; Chantal Mathieu; Marc Aerts
Journal:  Br J Gen Pract       Date:  2013-04       Impact factor: 5.386

4.  Comorbidity and glycemia control among patients with type 2 diabetes in primary care.

Authors:  Catherine Hudon; Martin Fortin; Marie-France Dubois; José Almirall
Journal:  Diabetes Metab Syndr Obes       Date:  2008-11-18       Impact factor: 3.168

5.  Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry.

Authors:  Roland E Schmieder; Anselm K Gitt; Cornelia Koch; Peter Bramlage; Taoufik Ouarrak; Diethelm Tschöpe
Journal:  BMC Endocr Disord       Date:  2015-05-02       Impact factor: 2.763

6.  Chronic illness with complexity: implications for performance measurement of optimal glycemic control.

Authors:  Pramod Meduru; Drew Helmer; Mangala Rajan; Chin-Lin Tseng; Leonard Pogach; Usha Sambamoorthi
Journal:  J Gen Intern Med       Date:  2007-12       Impact factor: 5.128

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.